GSK Consumer Sales Remain Strong As Rx Revenue Slips
Sales of GlaxoSmithKline's OTC and other consumer health care products far outpaced its prescription drugs, which brought overall sales down 3 percent in the firm's fiscal 2008 first quarter
Sales of GlaxoSmithKline's OTC and other consumer health care products far outpaced its prescription drugs, which brought overall sales down 3 percent in the firm's fiscal 2008 first quarter